HCPCS Level IIdrugActive
J9313
Inj., lumoxiti, 0.01 mg
BETOS: O1D
Effective: 2019-10-01
Description
Injection, moxetumomab pasudotox-tdfk, 0.01 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Lumoxiti
Manufacturer
AstraZeneca Pharmaceuticals LP
HCPCS Dosage
0.01 MG
Billing Units
100.0000
2
NDC Products
opps
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.